| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 08/02/2001 | CA2398561A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | CA2398548A1 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | CA2398435A1 Novel ligands and methods for preparing same |
| 08/02/2001 | CA2398430A1 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | CA2398227A1 17 human secreted proteins |
| 08/02/2001 | CA2398206A1 Pharmaceutical preparation and method for treatment of diabetes |
| 08/02/2001 | CA2397680A1 Use of fsh for treating infertility |
| 08/02/2001 | CA2397493A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/01/2001 | EP1119629A2 Oxidoreductase molecules |
| 08/01/2001 | EP1119571A2 Tricyclic delta3-piperidines as alpha2-antagonists |
| 08/01/2001 | EP1119570A1 Tricyclic delta3-piperidines as pharmaceuticals |
| 08/01/2001 | EP1119567A1 Quinazoline derivatives |
| 08/01/2001 | EP1119563A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 08/01/2001 | EP1119555A1 Biphenylene lactams as prostaglandin receptor ligands |
| 08/01/2001 | EP1119544A1 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators |
| 08/01/2001 | EP1119543A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 08/01/2001 | EP1119542A1 Prostaglandin receptor ligands |
| 08/01/2001 | EP1119354A1 Peripherally acting anti-pruritic opiates |
| 08/01/2001 | EP1119350A2 Rar antagonists as male anti-fertility agents |
| 08/01/2001 | EP0862567B1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 08/01/2001 | EP0737074B1 Botulinum toxins for treating hyperhydrosis |
| 08/01/2001 | CN1306535A Thienopyridine compounds, their prodn. and use |
| 08/01/2001 | CN1306534A Thienopyrimidines |
| 08/01/2001 | CN1306530A Paroxetine 10-camphorsulfonate for treament of CNS disorders |
| 08/01/2001 | CN1306439A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 08/01/2001 | CN1306434A Compsn. for prevention and/or treatment of osteoporosis and alterations due to menopause syndrome |
| 08/01/2001 | CN1306421A Matrix-type transdermal patch for steroid homones |
| 08/01/2001 | CN1305842A Chinese medicine for treating ovarian tumor |
| 08/01/2001 | CN1305840A Medicine for preventing and treating abortion |
| 08/01/2001 | CN1305837A Chinese medicine for treating male sexual disfunction |
| 08/01/2001 | CN1069098C Novel imidazole derivative and process for producing same |
| 08/01/2001 | CN1069062C Use of follicle-stimulating hormone |
| 08/01/2001 | CN1069058C Compound medicament for treating chronic pelvic inflammation |
| 08/01/2001 | CN1069030C Multifunctional collyrium for women |
| 07/31/2001 | US6268389 Treatment of urinary incontinence by administration of α1L-adrenoceptor agonists |
| 07/31/2001 | US6268369 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
| 07/31/2001 | US6268361 Estrogen dependent disorders including cancer, enodmetriosis, etc |
| 07/31/2001 | US6268344 Associated with sepsis, purpura fulminans, meningococcal sepsis, bone marrow and other transplantations, severe burns, pregnancy, major surgery, severe trauma, or ards. |
| 07/31/2001 | US6268337 Methods for treating vascular disorders using activated protein C |
| 07/29/2001 | CA2325930A1 A medicament for prevention and treatment of sexual dysfunction |
| 07/26/2001 | WO2001053489A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | WO2001053487A2 Human sperm specific lysozyme-like proteins |
| 07/26/2001 | WO2001053352A2 Sperm specific proteins |
| 07/26/2001 | WO2001053346A1 Human cystine knot polypeptide |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053339A2 Egg specific surface proteins |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053256A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same |
| 07/26/2001 | WO2001052857A1 Drospirenone for hormone replacement therapy |
| 07/26/2001 | WO2001052835A2 Free radical scavengers for the treatment of premature birth |
| 07/26/2001 | WO2000078933A3 Novel calpains and their use |
| 07/26/2001 | WO2000071741A9 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 07/26/2001 | WO2000059547A3 Method of detecting endometriosis |
| 07/26/2001 | WO2000017361A3 Interferon-epsilon |
| 07/26/2001 | US20010009962 One pot process for preparing sildenafil (drug for erectile dysfunction) and derivatives by reacting for example 4-(2-methoxy-5-(4-methyl-1-piperazinylsulfonyl)benzamido)-1-methyl-3-propyl -1H-pyrazole-5-carboxamide with ethanol |
| 07/26/2001 | US20010009680 Such as various cancers, by administering low molecular weight compounds of following properties: extractable from bile of an animal, stimulates monocytes and macrophages, modulates tumor necrosis factor production, not endotoxin |
| 07/26/2001 | DE10100779A1 Formulierung Formulation |
| 07/26/2001 | CA2398710A1 Egg specific surface proteins |
| 07/26/2001 | CA2397896A1 Human sperm specific lysozyme-like proteins |
| 07/26/2001 | CA2397838A1 Sperm specific proteins |
| 07/26/2001 | CA2397783A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | CA2397633A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | CA2397531A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same |
| 07/26/2001 | CA2396283A1 Human cystine knot polypeptide |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1117687A2 Compositions and methods for wt1 specific immunotherapy |
| 07/25/2001 | EP1117680A2 Ncam binding compounds |
| 07/25/2001 | EP1117421A2 Methods for therapeutic vaccination |
| 07/25/2001 | EP1117420A1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 07/25/2001 | EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/25/2001 | EP1117390A1 Mucosal originated drug delivery systems and animal applications |
| 07/25/2001 | EP0772610B9 Dihydrobenzofuranes |
| 07/25/2001 | EP0708657B1 Compositions for nasal administration of desmopressin |
| 07/25/2001 | CN1305488A Testosterone derivative |
| 07/25/2001 | CN1305478A Pyrazolopyrimidinone cGMP PDE 5 inhibitors for treatment of sexual dysfunction |
| 07/25/2001 | CN1305477A Azablicyclic 5-HT, receptor ligands |
| 07/25/2001 | CN1305454A Anthranilic acid derivatives as inhibitors of CGMP phosphodiesterase |
| 07/25/2001 | CN1304994A Yang-invigorating wine and its preparing process |
| 07/25/2001 | CN1304772A Process for preparing medicine to treating diseases in peripheral nerve system and male genetic defect |
| 07/25/2001 | CN1304755A Kidney-nourishing pill and its preparing process |
| 07/25/2001 | CN1304731A Exterior-applied Chinese patent medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer |
| 07/25/2001 | CN1068879C Dihydrobenzofuranes |
| 07/24/2001 | US6265543 Polypeptide for the treatment of eye disorders, tumors, cancer, psoriasis, trauma, psychological, burns and ulcers |
| 07/24/2001 | US6265410 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/24/2001 | US6265393 Continuous coadministration of low doses of an estrogen agent and a progestin agent to maintain an induced state of oligomenorrhea or amenorrhea in an afflicted woman. |
| 07/24/2001 | US6264953 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | CA2221753C Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast |
| 07/24/2001 | CA2193454C Bioadhesive pharmaceutical composition for the controlled release of active ingredients |
| 07/24/2001 | CA2042112C N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| 07/24/2001 | CA2031588C Substituted cyclohexanols and cyclohexylamines as central nervous system agents |
| 07/19/2001 | WO2001051642A2 Dna modification proteins |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051493A1 Benzosulfones with calcium antagonist activity |
| 07/19/2001 | WO2001051492A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors |
| 07/19/2001 | WO2001051472A1 New imidazole derivatives |
| 07/19/2001 | WO2001051471A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 07/19/2001 | WO2001051470A1 Phenanthridine-n-oxides |